Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
暂无分享,去创建一个
S. Yamaguchi | H. Nakamura | H. Tomoike | N. Nozaki | M. Shirakabe | Hidenori Nakamura | Seiji Yamaguchi | Naoki Nozaki
[1] H. Oral,et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.
[2] D. Mann,et al. Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .
[3] D. Fukai,et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. , 1995, The American journal of cardiology.
[4] W. Fiers,et al. Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.
[5] O. Febo,et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.
[6] T. LeJemtel,et al. Pathophysiological Correlates of Increased Serum Tumor Necrosis Factor in Patients With Congestive Heart Failure: Relation to Nitric Oxide‐Dependent Vasodilation in the Forearm Circulation , 1994, Circulation.
[7] W. Buurman,et al. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein. , 1994, Journal of immunology.
[8] S Sasayama,et al. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. , 1994, Circulation.
[9] L. Vaca,et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.
[10] C. Suschek,et al. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. , 1993, Journal of immunology.
[11] A. Cope,et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. , 1993, Arthritis and rheumatism.
[12] G. Morris,et al. Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.
[13] B. Aggarwal,et al. Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. Comparison with another tumor promoter, phorbol ester. , 1993, The Journal of biological chemistry.
[14] M. Brockhaus,et al. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. , 1992, The Journal of clinical investigation.
[15] F. Pagani,et al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. , 1992, The Journal of clinical investigation.
[16] Simon C Watkins,et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.
[17] L. Moldawer,et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Suter,et al. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. , 1992, Immunology.
[19] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.
[20] T. Gatanaga,et al. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. , 1991, Cellular immunology.
[21] J. McMurray,et al. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.
[22] D. Wallach,et al. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. , 1991, Cancer research.
[23] J. Vilček,et al. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. , 1991, The Journal of biological chemistry.
[24] K. Inouye,et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.
[25] U. Gullberg,et al. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. , 1990, The Journal of clinical investigation.
[26] R. Heller,et al. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[27] H. Fillit,et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.
[28] R. Gentz,et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. , 1990, Cytokine.
[29] J. Adams,et al. hypotension: Implications for the involvement of nitric oxide , 2022 .
[30] G. Wong,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.
[31] D. Hossfeld,et al. TNF-induced cardiomyopathy , 1990, The Lancet.
[32] D. Wallach,et al. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. , 1990, The Journal of biological chemistry.
[33] D. Wallach,et al. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. , 1989, The Journal of biological chemistry.
[34] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[35] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.
[36] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[37] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[38] H. Loetscher,et al. Tumor necrosis factor receptors-structure and function , 1992, Immunologic research.